NKTCL
Clinical trials for NKTCL explained in plain language.
Never miss a new study
Get alerted when new NKTCL trials appear
Sign up with your email to follow new studies for NKTCL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising new combo aims to shrink Early-Stage lymphoma before radiation
Disease control Not yet recruitingThis study tests a new combination of three drugs (sintilimab, pegaspargase, and selinexor) followed by radiation as a first treatment for people newly diagnosed with stage I or II extranodal NK/T-cell lymphoma, a rare blood cancer. About 47 adults will receive the drug combo fir…
Matched conditions: NKTCL
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 15, 2026 19:09 UTC
-
New drug duo targets hard-to-treat blood cancers
Disease control Not yet recruitingThis study tests two drugs, adebrelimab and SHR2554, together in about 40 adults whose T-cell lymphoma has come back or not responded to treatment. The goal is to find a safe dose and see if the combination can shrink tumors. Participants must have certain types of T-cell lymphom…
Matched conditions: NKTCL
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC